This article is from the source 'bbc' and was first published or seen on . It will not be checked again for changes.
You can find the current article at its original source at http://news.bbc.co.uk/go/rss/-/1/hi/health/7149463.stm
The article has changed 9 times. There is an RSS feed of changes available.
Version 0 | Version 1 |
---|---|
'Bubble boy' develops leukaemia | 'Bubble boy' develops leukaemia |
(10 minutes later) | |
One of the boys with no immune system being treated with pioneering gene therapy at Great Ormond Street has developed leukaemia, his doctors say. | One of the boys with no immune system being treated with pioneering gene therapy at Great Ormond Street has developed leukaemia, his doctors say. |
They said cancer was an "acknowledged risk" of this treatment for X-SCID, which is commonly known as "boy in the bubble syndrome". | They said cancer was an "acknowledged risk" of this treatment for X-SCID, which is commonly known as "boy in the bubble syndrome". |
A trial in France of the same therapy was halted in 2002 after three of ten children developed leukaemia. | A trial in France of the same therapy was halted in 2002 after three of ten children developed leukaemia. |
Ten children with X-SCID have so far been treated at the London hospital. | Ten children with X-SCID have so far been treated at the London hospital. |
All of these children "have seen clinical benefit", Professor Adrian Thrasher and Professor Bobby Gaspar, consultant immunologists on the gene therapy programme, said in a statement. | |
"This unfortunate event is the first such development on our programme." | |
X-SCID is caused by mutations in the IL2RG gene, which governs the behaviour of a protein involved in the development of a number of immune system cells. | |
Without the protein, the cells cannot develop normally, and are unable to protect the body. | |
The gene therapy works by replacing a defective gene. | |
French findings | |
But there had been warnings that there was a risk of cancer. | |
A US study last year published last year looked at the long-term effect of infecting the IL2RG gene into mice: A third of the animals developed a form of cancer, with most doing so when they were about 10 months old. | |
A few years previously a French trial was halted prematurely after three of ten boys treated were diagnosed with T-Cell leukaemia. | |
While nine of them had been cured of their original condition, French doctors said more work needed to be done to improve the safety of the treatment. | |
Last year, doctors at Great Ormond Street dismissed the findings of the US study as "unhelpful". | |
Professor Thrasher said then: "This is a very preliminary study published in an incomplete form. | |
"The researchers have taken artificially high doses of these genes and given them to animals. | |
"I'm not sure how it is relevant to human treatment. | |
"We know already that, in lower doses, the gene therapy does not have that effect." |